Sphera Franchise Group S.A. (BVB:SFG)

Verve Therapeutics Ratios and Metrics

Market cap in millions RON. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	1,501	1,562	994	543	582	570
Market Cap Growth	42.93%	57.09%	83.08%	-6.67%	2.04%	-21.81%
Enterprise Value	1,857	1,894	1,302	904	869	845
Last Close Price	38.85	39.23	23.62	11.78	11.91	11.07
PE Ratio	18.58	16.14	13.97	14.46	31.59	-
Forward PE	14.36	20.19	20.19	20.19	20.19	9.48
PS Ratio	0.97	1.01	0.68	0.41	0.58	0.80
PB Ratio	9.38	10.08	6.97	4.67	4.41	3.83
P/TBV Ratio	14.99	16.42	11.84	9.32	8.07	6.50
P/FCF Ratio	9.82	9.11	6.29	5.35	11.40	7.39
P/OCF Ratio	7.31	7.00	4.75	3.54	5.45	5.16
PEG Ratio	-	0.57	0.57	0.57	0.57	0.57
EV/Sales Ratio	1.20	1.22	0.89	0.68	0.87	1.19
EV/EBITDA Ratio	7.61	9.94	8.20	8.28	12.11	52.44
EV/EBIT Ratio	14.48	13.07	11.25	13.88	26.90	-
EV/FCF Ratio	12.15	11.04	8.23	8.91	17.02	10.94
Debt / Equity Ratio	2.76	2.96	2.82	3.71	3.56	2.65
Debt / EBITDA Ratio	1.81	1.78	1.82	2.58	3.65	5.75
Debt / FCF Ratio	2.89	2.68	2.54	4.25	9.20	5.11
Asset Turnover	2.15	2.09	2.09	1.84	1.43	1.10
Inventory Turnover	80.45	67.06	66.10	64.19	57.28	44.02
Quick Ratio	0.41	0.47	0.44	0.55	0.69	0.60
Current Ratio	0.50	0.56	0.53	0.62	0.78	0.66
Return on Equity (ROE)	49.96%	65.45%	55.41%	30.55%	13.28%	-5.98%
Return on Assets (ROA)	11.11%	12.20%	10.28%	5.65%	2.88%	-1.92%
Return on Capital (ROIC)	13.72%	15.63%	13.25%	7.08%	3.52%	-2.33%
Return on Capital Employed (ROCE)	25.70%	28.30%	25.60%	15.00%	6.70%	-
Earnings Yield	5.38%	6.19%	7.16%	6.91%	3.17%	-1.70%
FCF Yield	10.18%	10.98%	15.90%	18.68%	8.77%	13.54%
Dividend Yield	2.81%	2.78%	8.89%	14.22%	7.58%	8.15%
Payout Ratio	98.75%	82.44%	89.56%	92.41%	188.13%	-
Buyback Yield / Dilution	0.24%	0.05%	0.27%	-	-	-
Total Shareholder Return	3.05%	2.83%	9.16%	14.22%	7.58%	8.15%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.